The prior article in the two-part series challenged the traditional view of economics as merely the management of scarce ...

Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients ...

When a retailer offers a chatbot to communicate with customers and solve their queries, or when a bank sends an SMS for ...

Even though attendance in the office is crawling up, that growth is slowing, and the entire paradigm of how companies use ...

Investing.com -- Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) fell 1.2% following the U.S. Food and Drug Administration’s (FDA) Refusal to File (RTF) letter regarding the company’s New Drug ...

Axsome Therapeutics (AXSM) shares drop after FDA declines review of fibromyalgia treatment AXS-14. Read more here.

Bitcoin’s success reflects a growing shift in how the world approaches not only cryptocurrency but also financial markets as ...

Axsome Therapeutics received a refusal-to-file letter from the Food and Drug Administration for its new drug application for its fibromyalgia drug AXS-14.

The Nations League final wasn’t Lamine Yamal’s finest hour considering the ridiculous standards that he’d set himself over ...

Critics say renewables can't provide stable power. Supporters say we just need better equipment. Both sides are wrong. We ...

New Paradigm Theatre (NPT) will produce the lively musical Hairspray. Set in 1962 Baltimore, this beloved show captures the spirit of teenagers fighting for racial integration on their favorite TV ...

More than 15 years ago, my family doctor awakened me to a new world. “You have blood cancer,” she said. “But we may have ways ...